|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▼
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
PEGZILARGINASE |
A16AB24 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005484 |
15-12-2023 |
VALID
|
|
QUIZARTINIB |
L01EX11 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005910 |
06-11-2023 |
VALID
|
|
REZAFUNGIN |
J02AX08 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005900 |
22-12-2023 |
VALID
|
|
ROZANOLIXIZUMAB |
L04AG16 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005824 |
05-01-2024 |
VALID
|
|
TRASTUZUMAB |
L01XC03 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005769 |
15-11-2023 |
VALID
|
|
VAMOROLONE |
H02AB18 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005679 |
14-12-2023 |
VALID
|
|
ZILUCOPLAN |
L04AJ06 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005450 |
01-12-2023 |
VALID
|
|
CONJUGATED ESTROGENS |
G03CA57 |
FR
|
Not authorised
|
08-02-2024 |
|
|
VALID
|
|
CONJUGATED ESTROGENS AND BAZEDOXIFENE |
G03CC07 |
FR
|
I
|
08-02-2024 |
|
|
VALID
|
|
CYPROTERONE |
G03HA01 |
FR
|
I
|
08-02-2024 |
|
28-09-2001 |
VALID
|
|
NORETHISTERONE AND ESTROGEN |
G03FB05 |
FR
|
I
|
08-02-2024 |
|
|
VALID
|
|
PREDNISOLONE |
H02AB06 |
FR
|
I
|
08-02-2024 |
|
|
VALID
|
|
PROMESTRIENE |
G03CA09 |
FR
|
II
|
08-02-2024 |
|
28-09-2001 |
VALID
|
|
TIBOLONE |
G03CX01 |
FR
|
I
|
08-02-2024 |
|
|
VALID
|
|
DESOGESTREL |
G03AC09 |
FR
|
I
|
07-02-2024 |
|
|
VALID
|
|
ESTRADIOL |
G03CA03 |
FR
|
II
|
07-02-2024 |
FR/H/0237/001/ |
28-07-2005 |
VALID
|
|
ETHINYLESTRADIOL |
G03CA01 |
FR
|
II
|
07-02-2024 |
|
28-09-2001 |
VALID
|
|
MACROGOL |
A06AD15 |
FR
|
Not subject to prescription
|
07-02-2024 |
FR/H/0442/001/ |
22-05-2013 |
VALID
|
|
OLMESARTAN MEDOXOMIL AND DIURETICS |
C09DA08 |
FR
|
I
|
07-02-2024 |
|
|
VALID
|
|
PRULIFLOXACIN |
J01MA17 |
FR
|
Not authorised
|
01-12-2023 |
|
|
VALID
|
|
FERRIC MALTOL |
B03AB10 |
FR
|
Not authorised
|
21-11-2023 |
|
|
VALID
|
|
ATOGEPANT |
N02CD07 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005871 |
11-08-2023 |
VALID
|
|
FUTIBATINIB |
L01EN04 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005627 |
04-07-2023 |
VALID
|
|
GANAXOLONE |
N03AX27 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005825 |
26-07-2023 |
VALID
|
|
GLOFITAMAB |
L01FX28 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005751 |
07-07-2023 |
VALID
|
|
IVOSIDENIB |
L01XM02 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005936 |
04-05-2023 |
VALID
|
|
MIRIKIZUMAB |
L04AC24 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005122 |
26-05-2023 |
VALID
|
|
PEGUNIGALSIDASE ALFA |
A16AB20 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005618 |
04-05-2023 |
VALID
|
|
PIFLUFOLASTAT (18F) |
V09IX16 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005520 |
24-07-2023 |
VALID
|
|
RESPIRATORY SYNCYTIAL VIRUS VACCINES |
J07BX05 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/006027 |
23-08-2023 |
VALID
|
|
RITLECITINIB |
L04AF08 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/006025 |
15-09-2023 |
VALID
|
|
TALQUETAMAB |
L01FX29 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005864 |
21-08-2023 |
VALID
|
|
TISLELIZUMAB |
L01FF09 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005919 |
15-09-2023 |
VALID
|
|
UBLITUXIMAB |
L04AG14 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005914 |
31-05-2023 |
VALID
|
|
BUPRENORPHINE, COMBINATIONS |
N07BC51 |
FR
|
I
|
19-07-2023 |
EMEA/H/C/004407 |
10-11-2017 |
VALID
|
|
COMBINATIONS |
N01BB20 |
FR
|
II + Exemption
|
19-07-2023 |
EMEA/H/C/002693 |
15-11-2013 |
VALID
|
|
PAPAVERINE |
A03AD01 |
FR
|
Not subject to prescription
|
19-07-2023 |
|
|
VALID
|
|
PHOLCODINE |
R05DA08 |
FR
|
Not authorised
|
19-07-2023 |
|
|
VALID
|
|
VARIOUS COMBINATIONS |
B03AE10 |
FR
|
Not subject to prescription
|
19-07-2023 |
|
|
VALID
|
|
VORICONAZOLE |
J02AC03 |
FR
|
I
|
19-07-2023 |
|
|
VALID
|
|
FERRIC OXIDE POLYMALTOSE COMPLEXES |
B03AB05 |
FR
|
Not subject to prescription
|
18-07-2023 |
|
|
VALID
|
|
FERROUS SULFATE AND FOLIC ACID |
B03AD03 |
FR
|
Not subject to prescription
|
18-07-2023 |
|
|
VALID
|
|
SODIUM FEREDETATE |
B03AB03 |
FR
|
II
|
18-07-2023 |
|
|
VALID
|
|
IRINOTECAN |
L01CE02 |
FR
|
I
|
13-07-2023 |
FR/H/0334/001/ |
17-10-2014 |
VALID
|
|
RIFAMPICIN |
J04AB02 |
FR
|
I
|
13-07-2023 |
|
|
VALID
|
|
DENGUE VIRUS VACCINES |
J07BX04 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005155 |
05-12-2022 |
VALID
|
|
DEUCRAVACITINIB |
L04AF07 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005755 |
24-03-2023 |
VALID
|
|
ETRANACOGENE DEZAPARVOVEC |
B06XX00 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/004827 |
20-02-2023 |
VALID
|
|
GALLIUM (68GA) GOZETOTIDE |
V09IX14 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005488 |
09-12-2022 |
VALID
|
|
LONCASTUXIMAB TESIRINE |
L01FX22 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005685 |
20-12-2022 |
VALID
|
